PPARA and nonpapillary renal cell carcinoma: However, using only one ccRCC cell line for analyzing is the limitation in our research, so we intend to apply more renal cell carcinoma cell lines such as Caki-2 or UM-RC-2 for validating the roles of PPARα in different pathological patterns of RCC.